NASDAQ · Medical - Devices

TNDM (TNDM) Stock

$18.59 +4.67% NASDAQ: TNDM Healthcare

Valuation

MetricValue
Price$18.59
Market Cap$1.27B
P/E Ratio-105.31
P/B Ratio6.47
P/S Ratio0.98
EPS (TTM)$-1.37
52-Week High$29.65
52-Week Low$9.98
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-65.73%
ROA-3.68%
ROCE-50.32%
Gross Margin54.93%
Operating Margin-7.05%
Net Margin-9.20%
Debt/Equity5.55
Current Ratio3.58

Annual Financials (USD)

Metric20212022202320242025
Revenue$703.0M$801.0M$748.0M$940.0M$1.0B
Operating Profit$23.0M$-93.0M$-233.0M$-99.0M$-78.0M
Net Profit$16.0M$-95.0M$-223.0M$-96.0M$-205.0M
EPS$0.24$-1.47$-3.43$-1.47$-3.04
Op Margin3.2%-11.6%-31.2%-10.5%-7.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$905.0M$1.1B$953.0M$968.0M$881.0M
Total Liabilities$472.0M$613.0M$639.0M$705.0M$726.0M
Cash$71.0M$173.0M$59.0M$69.0M$91.0M
Borrowings$315.0M$420.0M$416.0M$474.0M$444.0M

Latest News

TNDM: Raising target price to $16.00 Argus Research · Jul 22, 2026 1 Unprofitable Stock with Exciting Potential and 2 Facing Challenges StockStory · Jul 17, 2026 Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks StockStory · Jul 16, 2026 Does Libre 3 Plus Integration Expand Tandem’s Interoperability Edge And Bull Case For TNDM? Simply Wall St. · Jul 12, 2026 Is Tandem Diabetes Care (TNDM) Undervalued Following Its Abbott Libre 3 Plus Expansion? Simply Wall St. · Jul 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$111.0M$50.0M$-32.0M$24.0M$-10.0M
Investing Cash Flow$-210.0M$-1.0M$-113.0M$-43.0M$53.0M
Financing Cash Flow$52.0M$-1.0M$4.0M$-30.0M$0
Net Cash Flow$-23.0M$101.0M$-114.0M$10.0M$21.0M
Free Cash Flow$88.0M$16.0M$-59.0M$5.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-27.11
FCF Yield-0.36%
Quick Ratio3.07
Interest Coverage-9.75
Return 1Y4.64%
Return 3Y-49.93%
Return 5Y-83.56%

Ownership

Insiders Held0.97%
Institutions Held117.80%
Institutions Float Held118.96%
Institutional HolderSharesReport Date
Blackrock Inc.10,690,8442026-03-31
Sessa Capital IM, L.P.4,730,7572026-03-31
Vanguard Portfolio Management LLC3,993,3332026-03-31
ArrowMark Colorado Holdings LLC3,103,6092026-03-31
Vanguard Capital Management LLC3,038,9192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
EYPT $12.41 +1.80% -4.34 $1.04B 0.00%
FTRE $18.43 +4.18% -1.26 $1.75B 0.00%
IART $19.76 +1.15% 5.27 $1.54B 0.00%
INMD $15.38 +1.38% 9.72 $884.05M 0.00%
KOD $41.58 -2.16% -8.11 $2.60B 0.00%

About TNDM

TNDM is led by CEO John F. Sheridan, employs 2,650 people, headquartered in US, publicly traded since 2013.

TNDM stock trades at $18.59 with a market capitalization of $1.27B. The stock is valued at a price-to-earnings (P/E) ratio of -105.31, price-to-book of 6.47, price-to-sales of 0.98. Over the past 52 weeks the stock has ranged between $9.98 and $29.65, and currently trades 37.3% below its 52-week high.

On profitability, TNDM generates a return on equity (ROE) of -65.73%, return on capital employed of -50.32%, an operating margin of -7.05%, a net profit margin of -9.20%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides